Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $36.2 million.

  • Camp4 Therapeutics' Net Cash Flow rose 45919.24% to $36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.7 million, marking a year-over-year increase of 25162.18%. This contributed to the annual value of $25.6 million for FY2024, which is 15753.39% up from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Net Cash Flow is $36.2 million, which was up 45919.24% from -$10.3 million recorded in Q2 2025.
  • Camp4 Therapeutics' Net Cash Flow's 5-year high stood at $61.5 million during Q4 2024, with a 5-year trough of -$14.7 million in Q1 2025.
  • Its 3-year average for Net Cash Flow is $3.1 million, with a median of -$10.8 million in 2024.
  • As far as peak fluctuations go, Camp4 Therapeutics' Net Cash Flow surged by 60850.36% in 2024, and later tumbled by 2966.55% in 2025.
  • Camp4 Therapeutics' Net Cash Flow (Quarter) stood at -$12.1 million in 2023, then skyrocketed by 608.5% to $61.5 million in 2024, then tumbled by 41.11% to $36.2 million in 2025.
  • Its Net Cash Flow stands at $36.2 million for Q3 2025, versus -$10.3 million for Q2 2025 and -$14.7 million for Q1 2025.